Alex Therapeutics announced that it has partnered with Navamedic to develop an app to be used alongside prescription ...

Elyse Blazevich discusses the Colorado Bioscience Association’s efforts to support the state’s life sciences sector by fostering partnerships, advocating for industry growth, and building a diverse ...

The legal challenges surrounding Biogen’s Aduhelm and Cassava Sciences’ simufilam underscore the ongoing difficulties in Alzheimer's drug development, leading to securities litigation over allegedly ...

As chief medical officer, Foley is expected to guide the clinical direction of True Digital Surgery and the advancement of ...

In this part of their Pharmaceutical Executive video interview, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, ...

Amid shifting operating dynamics in recent years, demands for external expertise have fluctuated—leaving those arrangements ...

Landmark results from the Phase III PURPOSE 2 trial found that lenacapavir demonstrated 89% greater efficacy than Truvada in ...

As new litigation looms in the debate over use of copay accumulator programs, a look at potential next moves for payers—and ...

Multi-region clinical trials can provide for varied results, but may not paint a full picture for a specific population.

Lilly Expands Manufacturing Footprint in Ireland with $1.8 Billion Investment. Eli Lilly and Company. September 12, 2024.

CVS Pharmacy Launches Birth Control Prescribing in Massachusetts. CVS Health. September 12, 2024.

WellSync is collaborating with Marius Pharmaceuticals to offer a testosterone replacement therapy (TRT) option on the ...